Analytical Overview: Heron Therapeutics Inc (HRTX)’s Ratios Tell a Financial Story

Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, Heron Therapeutics Inc’s stock clocked out at $1.76, up 0.57% from its previous closing price of $1.75. In other words, the price has increased by $0.57 from its previous closing price. On the day, 3.11 million shares were traded. HRTX stock price reached its highest trading level at $1.88 during the session, while it also had its lowest trading level at $1.71.

Ratios:

To gain a deeper understanding of HRTX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.74 and its Current Ratio is at 2.28.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on June 13, 2024, initiated with a Buy rating and assigned the stock a target price of $7.

On April 23, 2024, CapitalOne started tracking the stock assigning a Overweight rating and target price of $6.

Needham reiterated its Buy rating for the stock on March 13, 2024, while the target price for the stock was revised from $4 to $5.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HRTX now has a Market Capitalization of 267687216 and an Enterprise Value of 375043040. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.94. Its current Enterprise Value per Revenue stands at 2.723 whereas that against EBITDA is -65.855.

Stock Price History:

Over the past 52 weeks, HRTX has reached a high of $3.93, while it has fallen to a 52-week low of $1.04. The 50-Day Moving Average of the stock is 8.03%, while the 200-Day Moving Average is calculated to be -28.36%.

Shares Statistics:

It appears that HRTX traded 3.12M shares on average per day over the past three months and 9924200 shares per day over the past ten days. A total of 151.70M shares are outstanding, with a floating share count of 151.01M. Insiders hold about 0.71% of the company’s shares, while institutions hold 80.25% stake in the company. Shares short for HRTX as of 1732838400 were 27544540 with a Short Ratio of 8.93, compared to 1730332800 on 28810535. Therefore, it implies a Short% of Shares Outstanding of 27544540 and a Short% of Float of 23.400000000000002.

Most Popular